Scientific article

ABO-incompatible organ and bone marrow transplantation: current status

Published inTransplant international, vol. 16, no. 5, p. 291-299
Publication date2003

Despite the presence of preformed antibodies against AB oligosaccharide epitopes on the donor vascular endothelium, approximately one-third of ABO-incompatible organ allografts are not rejected by a humoral mechanism. With the growing immune-manipulation of the recipient, survival rates can be raised considerably, although they remain significantly inferior to those of ABO-compatible transplantation. Data from the Collaborative Transplant Study indicate a 1-year graft survival rate of approximately 50-60% following cadaveric ABO-incompatible kidney, liver or heart transplantation, compared with 70-80% for an ABO-compatible organ. The results for infants and young children, however, are very much better than those of adults, particularly for liver and heart transplantations, and the data suggest that B-cell tolerance can develop in the infant age group. We here review clinical and experimental experience with ABO-incompatible organ and bone marrow allotransplantation and address the mechanisms by which organs or cells survive in the presence of natural anti-carbohydrate antibodies.

  • ABO Blood-Group System/immunology
  • Bone Marrow Transplantation/immunology
  • Histocompatibility Testing
  • Humans
  • Immune Tolerance
  • Transplants
Citation (ISO format)
WU, Anette, BUEHLER, Leo Hans, COOPER, David K C. ABO-incompatible organ and bone marrow transplantation: current status. In: Transplant international, 2003, vol. 16, n° 5, p. 291–299. doi: 10.1007/s00147-003-0592-4
Main files (1)
Article (Published version)
ISSN of the journal0934-0874

Technical informations

Creation01/19/2015 4:28:00 PM
First validation01/19/2015 4:28:00 PM
Update time03/14/2023 10:44:37 PM
Status update03/14/2023 10:44:37 PM
Last indexation01/16/2024 4:24:20 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack